Pamela D. Garzone

1.6k total citations
33 papers, 1.3k citations indexed

About

Pamela D. Garzone is a scholar working on Surgery, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Pamela D. Garzone has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Pamela D. Garzone's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Alzheimer's disease research and treatments (3 papers). Pamela D. Garzone is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Alzheimer's disease research and treatments (3 papers). Pamela D. Garzone collaborates with scholars based in United States, United Kingdom and Spain. Pamela D. Garzone's co-authors include Patricia D. Kroboth, Matthew L. Sherman, Michael B. Atkins, Howard Edington, Jerome Ritz, Christine Canning, J W Mier, Michael J. Robertson, Linda A. Battiato and Michael S. Gordon and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Pamela D. Garzone

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pamela D. Garzone United States	14	445	390	300	167	135	33	1.3k
Yoko Tanaka Japan	23	210 0.5×	313 0.8×	402 1.3×	135 0.8×	145 1.1×	107	1.5k
Vimal Patel United States	21	360 0.8×	169 0.4×	555 1.9×	92 0.6×	142 1.1×	62	1.5k
Richard C. Chou United States	16	457 1.0×	120 0.3×	347 1.2×	86 0.5×	99 0.7×	29	1.2k
Michael Tagen United States	19	695 1.6×	354 0.9×	479 1.6×	57 0.3×	120 0.9×	33	1.7k
Arnold Lee New Zealand	24	187 0.4×	450 1.2×	595 2.0×	119 0.7×	142 1.1×	71	1.6k
Sara Bar‐Yehuda Israel	24	299 0.7×	395 1.0×	872 2.9×	51 0.3×	84 0.6×	33	2.0k
Pierre Giglio United States	25	123 0.3×	399 1.0×	610 2.0×	245 1.5×	128 0.9×	97	2.1k
Hiroki Chikumi Japan	20	214 0.5×	467 1.2×	991 3.3×	116 0.7×	68 0.5×	55	1.9k
Weidong Jin China	22	120 0.3×	583 1.5×	972 3.2×	174 1.0×	191 1.4×	87	1.9k
Carlo Avolio Italy	22	298 0.7×	306 0.8×	398 1.3×	73 0.4×	46 0.3×	75	1.8k

Countries citing papers authored by Pamela D. Garzone

Since Specialization

Citations

This map shows the geographic impact of Pamela D. Garzone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela D. Garzone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela D. Garzone more than expected).

Fields of papers citing papers by Pamela D. Garzone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela D. Garzone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela D. Garzone. The network helps show where Pamela D. Garzone may publish in the future.

Co-authorship network of co-authors of Pamela D. Garzone

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela D. Garzone. A scholar is included among the top collaborators of Pamela D. Garzone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela D. Garzone. Pamela D. Garzone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saed, Ghassan M., Nicole M. Fletcher, Toshima Z. Parris, et al.. (2024). Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer. SHILAP Revista de lepidopterología. 32(3). 200864–200864. 1 indexed citations

Markowski, Mark C., Deepak Kilari, Mario A. Eisenberger, et al.. (2021). Phase I study of CCW702, a bispecific small molecule-antibody conjugate targeting PSMA and CD3 in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 39(15_suppl). TPS5094–TPS5094. 8 indexed citations

Williams, Jason H., Chandrasekhar Udata, Bishu Ganguly, et al.. (2020). Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-α, in Adults with Type 1 Diabetes. The AAPS Journal. 22(2). 23–23. 10 indexed citations

Herold, Kevan C., Samantha Bucktrout, Bruce W. Bode, et al.. (2019). Immunomodulatory activity of humanized anti–IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes. JCI Insight. 4(24). 27 indexed citations

Gumbiner, Barry, Brooke Esteves, Tenshang Joh, et al.. (2018). Single and multiple ascending-dose study of glucagon-receptor antagonist RN909 in type 2 diabetes: a phase 1, randomized, double-blind, placebo-controlled trial. Endocrine. 62(2). 371–380. 13 indexed citations

Fazio, Sergio, David Robertson, Tenshang Joh, et al.. (2017). Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high‐dose statin. Cardiovascular Therapeutics. 36(1). 15 indexed citations

Gumbiner, Barry, Tenshang Joh, Liang Hong, et al.. (2017). The effects of single‐ and multiple‐dose administration of bococizumab (RN316/PF‐04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies. Cardiovascular Therapeutics. 36(1). 14 indexed citations

Wan, Hong, et al.. (2017). Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition with Bococizumab on Lipoprotein Particles in Hypercholesterolemic Subjects. Clinical Therapeutics. 39(11). 2243–2259.e5. 10 indexed citations

Udata, Chandrasekhar, Pamela D. Garzone, Barry Gumbiner, et al.. (2017). A Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for Bococizumab, a Humanized Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, and Its Application in Early Clinical Development. The Journal of Clinical Pharmacology. 57(7). 855–864. 8 indexed citations

10.

Hamid, Omid, John A. Thompson, Adi Diab, et al.. (2016). First in human (FIH) study of an OX40 agonist monoclonal antibody (mAb) PF-04518600 (PF-8600) in adult patients (pts) with select advanced solid tumors: Preliminary safety and pharmacokinetic (PK)/pharmacodynamic results.. Journal of Clinical Oncology. 34(15_suppl). 3079–3079. 22 indexed citations

11.

Wan, Hong, et al.. (2013). EFFECTS OF RN316 (PF-04950615), A HUMANIZED IGG2ΔA MONOCLONAL ANTIBODY BINDING PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9, ON LIPOPROTEIN PARTICLES IN HYPERCHOLESTEROLEMIC SUBJECTS. Journal of the American College of Cardiology. 61(10). E1387–E1387. 4 indexed citations

12.

Bigal, Marcelo E., Rafael Escandón, Michele Bronson, et al.. (2013). Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program. Cephalalgia. 34(7). 483–492. 76 indexed citations

13.

Chaparro‐Riggers, Javier, Liang Hong, Rachel M. DeVay, et al.. (2012). Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9. Journal of Biological Chemistry. 287(14). 11090–11097. 137 indexed citations

14.

Garzone, Pamela D. & Arthur J. Atkinson. (2012). In Search of Physiologically Based Distribution Volume Estimates for Macromolecules. Clinical Pharmacology & Therapeutics. 92(4). 419–421. 6 indexed citations

15.

Wartchow, Charles, Susan E. Alters, Pamela D. Garzone, et al.. (2004). Enhancement of the Efficacy of An Antagonist of an Extracellular Receptor by Attachment to the Surface of a Biocompatible Carrier. Pharmaceutical Research. 21(10). 1880–1885. 1 indexed citations

16.

Singer, Jack W., Brian Baker, Peter de Vries, et al.. (2004). Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103) [XYOTAX™], a Biodegradable Polymeric Drug Conjugate. Advances in experimental medicine and biology. 519. 81–99. 124 indexed citations

17.

Garzone, Pamela D., et al.. (1995). Pain Perception and Serum Beta-Endorphin in Trauma Patients. Psychosomatics. 36(3). 276–284. 7 indexed citations

18.

Fleishaker, Joseph C., et al.. (1995). Comparison of the spectrum of cognitive effects of alprazolam and adinazolam after single doses in healthy subjects. Psychopharmacology. 120(2). 169–176. 13 indexed citations

19.

Garzone, Pamela D. & Patricia D. Kroboth. (1989). Pharmacokinetics of the Newer Benzodiazepines. Clinical Pharmacokinetics. 16(6). 337–364. 132 indexed citations

20.

Garzone, Pamela D., James A. Lyon, & Victor L. Yu. (1983). Third-Generation and Investigational Cephalosporins: I. Structure-Activity Relationships and Pharmacokinetic Review. Drug Intelligence & Clinical Pharmacy. 17(7-8). 507–515. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact